- About
- Advertise
- CureToday.com
- OncLive.com
- OncNursingNews.com
- TargetedOnc.com
- Contact
- Terms and Conditions
- Privacy
- Do Not Sell My Personal Information
© 2022 MJH Life Sciences™ and Cancer Network. All rights reserved.
Stacey A. Cohen, MD | Authors
Ongoing Trials and Future Directions in CRC
June 02, 2022
Drs. Cohen and Lewis close by outlining ongoing clinical trials in CRC and hopes for the future of care.
Key GALAXY Takeaways and Clinical Implications
May 26, 2022
Stacy A. Cohen, MD and Mark Lewis, MD share key takeaways from the GALAXY study and discuss the clinical implications of using ctDNA-based assays for patients with CRC.
GALAXY: Cumulative ctDNA Clearance Rates by ACT Receipt
May 26, 2022
Experts describe cumulative ctDNA clearance rates in patients with stage I-IV disease who did or did not receive adjuvant chemotherapy in the GALAXY study.
GALAXY: DFS by Stage and ACT Receipt in ctDNA-Positive Patients
May 19, 2022
Stacy A. Cohen, MD, and Mark Lewis, MD, discuss how DFS correlates with stage and adjuvant chemotherapy receipt in patients who are ctDNA-positive.
GALAXY: DFS by ctDNA Status at Weeks 4 and 12 Post Surgery
May 19, 2022
GI oncologists discuss DFS data from the dynamics analysis cohort of the GALAXY study.
Previous Trials of ctDNA Analysis in Patients With CRC
May 12, 2022
Mark Lewis, MD, provides a historical perspective of circulating tumor DNA and discusses previous trials on ctDNA analysis in patients with CRC.
GALAXY: Disease-Free Survival by Stage and ctDNA Status
May 12, 2022
Stacy A. Cohen, MD, and Mark Lewis, MD, comment on disease-free survival rates by ctDNA status in patients enrolled in the GALAXY study.
GALAXY Study Enrollment and Patient Cohorts
May 05, 2022
Drs Cohen and Lewis review the GALAXY enrollment strategy and describe the various colorectal cancer patient cohorts in the study.
Introduction and CIRCULATE-Japan Overview
May 05, 2022
Stacey A. Cohen, MD, and Mark Lewis, MD, introduce the 2022 ASCO GI abstract, “Association of Circulating Tumor DNA Dynamics With Clinical Outcomes in the Adjuvant Setting for Patients With Colorectal Cancer From an Observational GALAXY Study in CIRCULATE-Japan.”